Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene

Related Experiment Video

Updated: Oct 17, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

T Tolkacheva1, A M Chan

  • 1The Derald H Ruttenberg Cancer Center, The Mount Sinai School of Medicine, New York, NY 10029, USA.

Oncogene
|March 4, 2000
PubMed

Insights

The PTEN tumor suppressor gene inhibits Ras oncogene activity and cell transformation. Its C-terminal region is crucial for this anti-oncogenic function and maintaining protein stability.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • PTEN (also known as MMAC1/TEP1) is a tumor suppressor gene encoding a phosphatase.
  • Mutations in PTEN are linked to endometrioid uterine tumors and Ras oncogene activation.
  • Ras oncogenes are frequently activated in various cancers.

Purpose of the Study:

  • To investigate the anti-oncogenic activity of PTEN against Ras-induced cellular transformation.
  • To identify the minimal region of PTEN responsible for its tumor-suppressive function.
  • To explore the correlation between PTEN's anti-oncogenic activity and its phosphatase function.

Main Methods:

  • Utilized NIH3T3 cells for transformation assays.
  • Generated carboxyl-terminal truncation mutants of PTEN.
  • Assessed inhibition of H-Ras induced morphological transformation and anchorage-independent growth.
  • Measured in vitro dephosphorylation of inositol (1,3,4,5)-tetrakisphosphate.
  • Evaluated suppression of Akt kinase activity.

Main Results:

  • PTEN potently inhibited H-Ras induced morphological transformation and anchorage-independent growth.
  • PTEN's inhibitory activity was linked to suppression of the phosphatidylinositol 3-kinase (PI3-K) pathway, not the MAPK pathway.
  • Truncation of 68 amino acids from the C-terminus significantly reduced PTEN's ability to inhibit Ras transformation.
  • Mutant PTEN's efficacy correlated with its in vitro phosphatase activity and in vivo Akt kinase suppression.
  • Evidence suggests the C-terminal region stabilizes the PTEN protein.

Conclusions:

  • PTEN possesses potent anti-oncogenic activity against Ras transformation, primarily through PI3-K pathway suppression.
  • The C-terminal region of PTEN is critical for its anti-oncogenic function and protein stability.
  • PTEN's phosphatase activity is essential for its tumor suppressor role.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...